Cargando…

Identification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH Medulloblastoma

SIMPLE SUMMARY: Medulloblastoma is the most common malignant pediatric brain tumor. It can be divided into four molecular subgroups with clear biological and clinical differences: Group 3, Group 4, SHH, and WNT. The Group 3 subgroup has the lowest overall survival rate, and the WNT subgroup has the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westphal, Maximillian S., Lee, Eunjee, Schadt, Eric E., Sholler, Giselle S., Zhu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750188/ https://www.ncbi.nlm.nih.gov/pubmed/35008302 http://dx.doi.org/10.3390/cancers14010139

Ejemplares similares

The transcriptional landscape of Shh medulloblastoma
por: Skowron, Patryk, et al.
Publicado: (2021)

Evasion of cell senescence in SHH medulloblastoma
por: Tamayo-Orrego, Lukas, et al.
Publicado: (2016)

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
por: Remke, Marc, et al.
Publicado: (2013)

Principles of tumorigenesis and emerging molecular drivers of SHH‐activated medulloblastomas
por: Menyhárt, Otília, et al.
Publicado: (2019)

Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma
por: Caimano, Miriam, et al.
Publicado: (2021)

Survival of Naïve T Cells Requires the Expression of Let-7 miRNAs
por: Pobezinskaya, Elena L., et al.
Publicado: (2019)

Let-7 miRNA’s Expression Profile and Its Potential Prognostic Role in Uterine Leiomyosarcoma
por: de Almeida, Bruna Cristine, et al.
Publicado: (2019)

The Role of miRNA in Papillary Thyroid Cancer in the Context of miRNA Let-7 Family
por: Perdas, Ewelina, et al.
Publicado: (2016)

Auto-regulation of miRNA biogenesis by let-7 and Argonaute
por: Zisoulis, Dimitrios G., et al.
Publicado: (2012)

Biogenesis and regulation of the let-7 miRNAs and their functional implications
por: Lee, Hosuk, et al.
Publicado: (2015)

Clinical significance of the expression of miRNA-21, miRNA-31 and miRNA-let7 in patients with lung cancer
por: Wang, Sheng, et al.
Publicado: (2019)

M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas
por: Lee, Chanhee, et al.
Publicado: (2018)

Disruption of rack1 suppresses SHH‐type medulloblastoma formation in mice
por: Liu, Fengjiao, et al.
Publicado: (2021)

BIOL-08. IGFBP2 PROMOTES TUMOR METASTASIS IN SHH MEDULLOBLASTOMA
por: Kunhiraman, Haritha, et al.
Publicado: (2021)

EMBR-19. SHH-DRIVEN MEDULLOBLASTOMA WITH CONCURRENT UNILATERAL RENAL AGENESIS
por: Aaroe, Ashley, et al.
Publicado: (2021)

Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progression
por: Wynn, Daniel T, et al.
Publicado: (2022)

Defining Transcriptional Regulatory Mechanisms for Primary let-7 miRNAs
por: Gaeta, Xavier, et al.
Publicado: (2017)

The insights of Let‐7 miRNAs in oncogenesis and stem cell potency
por: Sun, Xin, et al.
Publicado: (2016)

Genetic robustness of let-7 miRNA sequence–structure pairs
por: He, Qijun, et al.
Publicado: (2019)

Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma
por: Aly, Doaa Mamdouh, et al.
Publicado: (2020)

Differential Expression of Mitochondrial Biogenesis Markers in Mouse and Human SHH-Subtype Medulloblastoma
por: Łastowska, Maria, et al.
Publicado: (2019)

Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma
por: Azzollini, Jacopo, et al.
Publicado: (2020)

Crosstalk between SHH and FGFR Signaling Pathways Controls Tissue Invasion in Medulloblastoma
por: Neve, Anuja, et al.
Publicado: (2019)

Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironment
por: Tamayo-Orrego, Lukas, et al.
Publicado: (2019)

The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
por: Ghasemi, David R., et al.
Publicado: (2022)

EPCT-17. DEVELOPING EYA PHOSPHATASE INHIBITORS WITH ON-TARGET EFFECTS IN SHH-MEDULLOBLASTOMA
por: H. Hwang, Grace, et al.
Publicado: (2021)

EMBR-33. YAP1 FUNCTION IN SHH MEDULLOBLASTOMA PROGRESSION AND IMMUNE EVASION
por: Abdelfattah, Nourhan, et al.
Publicado: (2021)

MEDB-48. Infant medulloblastoma - SHH subtype – with residual disease. To treat or not to treat
por: Dahl, Christine, et al.
Publicado: (2022)

MEDB-66. Investigating intra-tumoral heterogeneity of extrachromosomal DNA in SHH medulloblastoma
por: Chapman, Owen, et al.
Publicado: (2022)

Sex differences in methylation profiles are apparent in medulloblastoma, particularly among SHH tumors
por: Moss, Rachel M., et al.
Publicado: (2023)

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
por: Dang, Mai T., et al.
Publicado: (2021)

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
por: Dang, Mai T., et al.
Publicado: (2023)

Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy
por: Zhang, Zhen-Yu, et al.
Publicado: (2014)

Modulation of let-7 miRNAs controls the differentiation of effector CD8 T cells
por: Wells, Alexandria C, et al.
Publicado: (2017)

Analysis of Let-7 Family miRNA in Plasma as Potential Predictive Biomarkers of Diagnosis for Papillary Thyroid Cancer
por: Perdas, Ewelina, et al.
Publicado: (2020)

LINE-1 retrotransposons and let-7 miRNA: partners in the pathogenesis of cancer?
por: Ohms, Stephen, et al.
Publicado: (2014)

Role of miRNA Let-7 and Its Major Targets in Prostate Cancer
por: Wagner, Siegfried, et al.
Publicado: (2014)

let-7 MicroRNA-Mediated Regulation of Shh Signaling and the Gene Regulatory Network Is Essential for Retina Regeneration
por: Kaur, Simran, et al.
Publicado: (2018)

Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma
por: Fang, Huangyi, et al.
Publicado: (2023)

Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma
por: Lozier, Ann M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_21a7c8vqprrkc5ela6lqlmehst